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EFFECT OF DIETARY BETA-AGONIST SUPPLEMENTATION ON LIVE 
PERFORMANCE, CARCASS CHARACTERISTICS, CARCASS FABRICATION YIELDS, 
AND STRIP LOIN TENDERNESS AND SENSORY TRAITS 
 Beef steers (n = 3,906) were fed at a commercial feed yard to evaluate the effects of beta-
adrenergic agonist supplementation on live performance, carcass characteristics, carcass 
fabrication yield and strip loin tenderness and palatability.  Steers were weighed and ultrasonic 
carcass measurements were collected for allocation into four feeding blocks.  Within each block, 
approximately 100 steers were assigned two a pen that was assigned one of five treatments, 
including: No beta-agonist; Ractopamine hydrochloride (RH) fed at 200 mg/hd/d for the final 30 
d of finishing (RAC200); RH fed at 300 mg/hd/d for the final 30 d of finishing (RAC300); RH 
fed as a 400 mg/hd/d top dress for the final 30 d of finishing (RAC400); and Zilpaterol 
hydrochloride (ZH) fed at 6.8 g/ton beginning 23 d before slaughter, with a withdrawal period 
starting 3 d before to slaughter (ZIL).  The study design included eight replicates (pens) per 
treatment (two per block).  Each feeding block was harvested on consecutive weeks.  Each week, 
carcass parameters were measured and strip loin samples were collected from 18 carcasses per 
pen (720 total samples) for Warner-Bratzler and Slice Shear Force, and trained sensory analysis.  
Subsamples of eight carcasses per pen (320 total samples) were selected for whole carcass 
fabrication yield. 
 Final BW was not affected by treatment (P = 0.2892), but there was a tendency for cattle 
receiving βAA supplementation to be heavier compared to controls (P = 0.0681).  Average daily 
gain and F:G ratio was improved with treatment of βAA (P < 0.05).  Carcasses from the ZIL and 
RAC400 treatments had the heaviest HCW, and were significantly heavier than CON and 
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RAC200 treatments (P < 0.05).  The ZIL treatment also recorded the highest dressing percent 
and carcasses had the largest LMA compared to all other treatments (P < 0.05).  USDA yield 
grade and marbling score were reduced due to βAA supplementation (P < 0.05).  Differences in 
marbling score reduced the frequency of carcass qualifying for the CAB premium in βAA treated 
cattle (P < 0.05), while also accounting for a decrease in the frequency of carcasses grading 
choice and an increase in the percentage of carcasses grading select for cattle receiving βAA 
supplementation compared to controls (P < 0.05).  The percentage of YG1 carcasses was 
increased and the frequency of YG3 carcasses was decreased due to βAA treatment (P < 0.05).  
Treatment with dietary βAA elicited the greatest response in subprimal yield in cuts from the 
round.  Zilpaterol treatment carcasses reported the highest total saleable yield, and were greater 
than all RAC treatments (P < 0.05).  Warner-Bratzler and SSF was affected by treatment (P < 
0.05), with an increase in shear force values with increased dose and potency of βAA’s.  
Likewise, the percentage of steaks shearing greater than 4.4 and 20 kg for WBSF and SSF, 
respectively, was increased with βAA supplementation (P < 0.05).  Tenderness attributes were 
ranked lower for steaks from βAA treatments by trained sensory panelists (P < 0.05).  There 
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 Growth enhancement technologies have been widely used in livestock production for 
many years.  For decades, they have been an integral part of the livestock feeding industry, and 
producers have continued to utilize these technologies to improve efficiency in cattle and hog 
feeding systems.   
The current state of the livestock production and the economy has dictated an increased 
use of pharmacological agents to make beef and pork production more efficient and affordable.  
The recent economic recession, widespread drought, and consistent increases in input costs have 
had negative impacts on the margins cattle and hog feeders recognize when producing and 
selling livestock.  Consequently, the hog industry, and more recently, the cattle feeding industry 
have increased utilization of beta-adrenergic agonists to improve the efficiency of production.  
While the use of Ractopamine hydrochloride (Paylean
®
, Elanco Animal Health, Greenfield, IN) 
has been used extensively in hog production since its approval by the Food and Drug 
Administration in 1999, similar pharmaceutical feed additives have only recently been 
implemented in commercial cattle feeding operations.  Beta-adrenergic agonist use in fed cattle 
has substantially increased following the FDA approval of Ractopamine hydrochloride 
(Optaflexx
®
, Elanco Animal Health, Greenfield, IN) in 2003, and the approval of Zilpaterol 
hydrochloride (Zilmax
®
, Merck Animal Health, Summit, NJ) in 2006.   
For decades, cattle producers have primarily used hormonal implants to enhance live 
animal growth in fed cattle.  For over 50 years, estrogenic and androgenic hormone implants 
were widely used in the cattle feeding industry, and it is estimated that approximately 97 percent 
of feedlot cattle in the U.S. receive one or more implants during the finishing phase (Barham et 
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al., 2003; Tatum, 2006).  There is a large body of literature that indicates the positive growth 
enhancement effects which implants impart on growing and finishing cattle and producers have 
extensively used implants to increase live body weight, improve average daily gain and feed 
efficiency, and reduce the number of days cattle are on feed (Apple et al., 1991; Duckett et al., 
1997; Milton and Horton, 1996; Perry et al., 1991). 
Likewise, there is a growing body of literature that indicates the positive response on 
growth and carcass characteristics that finishing cattle have to beta-adrenergic agonists.  The use 
of both Ractopamine and Zilpaterol have shown to elicit similar improvements in live weight 
gain, average daily gain, and feed efficiency as those reported in hormone implants (Allen et al., 
2009; Avendaño-Reyes et al., 2006; Beckett et al., 2009; Elam et al., 2009; Gruber et al., 2007; 
Kellermeier et al., 2009; Scramlin et al., 2010).  In addition, these compounds have been 
reported to have profound effects on hot carcass weight, Longissimus muscle area and carcass 
cutability (Gruber et al., 2007; Hilton et al., 2010; Rathmann et al., 2009; Scramlin et al., 2010; 
Shook et al., 2009; Vogel et al., 2009).  It is because of this that cattle feeders have drastically 
increased use of beta-agonists since their FDA approval, and a growing portion of the fed cattle 
population receive both a hormone implant, as well as a dietary beta-agonist supplement that is 
provided within the final 20 to 30 d of finishing. 
While the efficacy of these compounds is well documented, so too are the negative 
effects on meat quality.  The use of both Ractopamine and Zilpaterol has corresponded to 
increased toughness in meat from cattle given a dietary supplement of either compound 
(Avendañ0-Reyes et al., 2006; Garmyn et al., 2010; Gruber et al., 2008; Leheska et al., 2009; 
Woerner et al., 2011).  Likewise, beta-agonists have been reported to decrease marbling scores, 
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while also negatively affecting the percentage of cattle qualifying for quality-based premiums 
(Kellermeier et al., 2009; Vasconcelos et al., 2008). 
It is because of these factors that the use of beta-agonists has come under recent scrutiny.  
The positive effects of dietary beta-agonist supplementation has allowed cattle feeders to 
improve efficiency and packers to improve yields; however, packers also face the issue of lower 
quality carcasses and retailers are required to market products that could provide consumers with 
a less desirable eating experience.  Researchers continue to analyze the effects of beta-agonist 
supplementation at different doses, potencies, and feeding periods, as well as differential effects 
on cattle of varying biological type.  Determining the optimal dose, as well as the preferential 
cattle type for beta-agonist supplementation, will aid in optimizing the positive effects on growth 
while mitigating the negative effects on quality across the population at-large. 
Currently, there is a considerable volume of literature detailing the effects of 
Ractopamine and Zilpaterol on live animal growth, carcass characteristics, and tenderness; yet, 
there are few studies which directly compare effects both compounds in a controlled study.  
Likewise, there are no known published studies evaluating the effect of Ractopamine on 
subprimal yield and carcass cutability in beef cattle.  The objective of this study was to compare 
the effect of three different doses of Ractopamine hydrochloride and one dose of Zilpaterol 
hydrochloride to an implanted control on live animal growth, carcass characteristics, carcass 







REVIEW OF LITERATURE 
Introduction 
 Beef producers constantly strive to improve the productivity of cattle.  Decreases in the 
size of the U.S. cattle herd over the past 15 years and rising cost of inputs has exacerbated the 
need to make the production of beef more efficient and affordable.  As production enhancing 
technologies have evolved, cattle producers have used them to maximize efficiency from their 
cattle and improve profitability.  Currently, there is an array of growth promoting technologies 
available, and feeders can combine steroid hormone implantation with β-adrenergic agonist 
(βAA) supplementation regimens to substantially improve feedlot cattle performance. 
 Cattle feeders have utilized steroidal implants in beef cattle for well over 50 years 
(Barham et al., 2003).  Implantation of estrogenic and androgenic hormones improves growth 
efficiency of feedlot cattle by increasing final body weight, decreasing days on feed, and 
improving dry matter intake per kg of gain (Perry et al., 1991).  Implants are still used in the 
majority of cattle on feed, and feeders often use different combinations of hormones and implant 
types to achieve maximal feed efficiency and growth from their cattle. 
 The efficacy of βAA on lean efficiency enhancement is widely recognized and has been a 
topic of research for more than three decades.  However, βAA use in the cattle industry was 
limited until Ractopamine hydrochloride (RH) was approved by the Federal Drug Administration 
(FDA) in 1999 for use in swine and Zilpaterol hydrochloride (ZH) was approved in 2006 for use 
in cattle.  The approval of both βAA‘s has allowed cattle feeders to combine growth promoting 
effects of steroidal implants with repartitioning agents, which increase growth and performance, 
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increase skeletal muscle accretion and improve overall carcass yield (Kellermeier et al., 2009; 
Parr et al., 2011; Perry et al., 1991). 
 Along with improvements in live weight and carcass gains, supplementation of cattle 
with βAA has come under scrutiny due to deleterious impacts on meat quality.  Multiple studies 
(Gruber et al., 2008; Hilton et al., 2009; Kellermeier et al., 2009; Mehaffey et al., 2009; 
Vasconcelos et al., 2008) showed that feeding βAA reduces tenderness in steaks from the 
longissimus muscle (LM).  Furthermore, βAA supplementation decreases quality grade and 
reduces the proportion of cattle grading choice (Beckett et al., 2009; Elam et al., 2009; Hilton et 
al., 2009; Kellermeier et al., 2009). 
 Supplementation of cattle with βAA is becoming more widespread in the beef industry.  
Yet, there is a necessity to better understand the biological type of cattle for which 
supplementation with βAA can be most advantageous.  The positive and negative effects of βAA 
can be balanced by utilizing cattle which can reap the most benefit from live and carcass weight 
gains, but limit the reductions or consequences to consumer demand of reduced marbling score 
and tenderness.  Data suggest that RH supplementation of cattle with a higher percentage British 
influence can provide the best combination of lean muscle gain and maintenance of carcass 
quality (Gruber et al., 2007; Gruber et al., 2008).  Holstein and dairy type cattle also have been 
the subject of βAA research (Allen et al., 2009; Beckett et al., 2009; Garmyn et al., 2010; Vogel 
et al., 2009); objectives were to increase skeletal muscle mass and carcass yield.   
 Research on βAA mode of action, amount and duration of supplementation, and positive 
and negative effects on live performance and carcass parameters continues to be a major area of 
beef cattle and meat science research as βAA use becomes more widely implemented.  
Growth Improvement in Livestock 
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 A primary focus of beef production is using technologies to improve efficiency and 
decrease the cost of gain.  While much progress has been made through genetic improvement in 
terminal livestock, beef producers have complimented that improvement with the adaptation of 
growth enhancement technologies.  Anabolic growth implants have been utilized by beef 
producers for over 50 years to improve efficiency of fed beef cattle (Bruns et al., 2005).  Use of 
naturally occurring steroid hormones, as well as the development of synthetic steroids, has 
offered cattle producers the opportunity to improve live animal performance, feed efficiency, and 
carcass yield (Perry et al., 1991). 
 More recently, the widespread use of βAA’s have provided an additional method for 
improving beef cattle growth and carcass yield (Gruber et al., 2007; Kellermeier et al., 2009).  
Used as a feed additive, the use of two different commercial βAA improve growth beyond that of 
conventional implant strategies (Elam et al., 2009; Gruber et al., 2007). 
Hormone Implants 
 The first growth promoting hormone approved for use in livestock was diethylstilbestrol 
(DES) in 1954 (Preston, 1999).  However, this compound later was banned by the FDA in 1979 
due to potential carcinogenic effects when used by humans, not in animals (Preston, 1999).  
Shortly after the approval of DES, estradiol benzoate (EB) and progesterone implants were 
approved for use in steers in 1956, and later in heifers in 1958 (Preston, 1999).  The approval of 
zeranol, a synthetically derived estrogen, and trenbolone acetate (TBA), a synthetic androgen, 
followed in 1969 and 1987, respectively (Preston, 1999). 
 Estradiol benzoate, estradiol (E2), and zeranol are the most commonly used estrogenic 
hormones, while TBA is the common androgen utilized in growth enhancement (Tatum, 2006).  
In the last two decades, combinations of E2/EB and TBA in implants, in varying potencies and 
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under multiple release scenarios, are commonly used in fed beef cattle to enhance growth over 
single compound implant strategies (Preston, 1999; Tatum, 2006).   
Normal growth in livestock is primarily controlled by estrogenic and androgenic 
hormones – estrogen and testosterone.  Estrogen hormones act on the anterior pituitary to 
increase secretion of growth hormone (GH) or somatotropin, which then increases production of 
insulin-like growth factor I (IGF-I) from both the liver and locally in bone and skeletal muscle 
(Trenkle, 1997).  Circulating GH binds to specified GH receptors on the liver to increase 
production of IGF-I, which is transported by IGF-I binding proteins to tissues and acts to 
increase protein accretion and stimulate long bone growth (Hossner, 2005).  Insulin-like growth 
factor binds to a specified IGF-receptor and activates the PI3-Kinase pathway to increase protein 
accretion.  In addition, increased IGF-I has been shown to increase satellite cell proliferation, 
which serves as the DNA content to increase muscle hypertrophy (Johnson et al., 1998).  
Comparatively, androgen hormones work directly on androgen receptors on muscle cells 
(Heitzman, 1979).  While the mode of action is not well understood, it is expected androgens 
elicit a response through both an intracellular signaling cascade which stimulate protein 
accretion, while also blocking the potential catabolic effects of glucorticoid hormones, which 
have a similar affinity for androgen cell receptors (Wu, 1997).  Additionally, testosterone is 
capable of aromatizing to estrogen in vivo, providing additional anabolic affects identical to the 
aforementioned mechanisms by which estrogens act (Wu, 1997).  It is because of these 
independent mechanisms by which estrogens and androgens impart their physiological effects 
that estradiol and TBA are used in combination to produce additive anabolic affects in implanted 
cattle (Trenkle, 1997). 
8 
 
 The use of combined anabolic implants affects animal growth in the same manner as 
those naturally occurring in vivo.  Johnson et al. (1996) reported that steers implanted with a 
combined E2 and TBA implant had 16 and 22 percent greater circulating IGF-I concentrations 
after 21 and 40 d of implantation, respectively.  Furthermore, Johnson et al. (1998) reported that 
satellite cell cultures isolated from cattle receiving a combined E2 plus TBA implant had a 
greater maximum cell fusion percentage than from cattle receiving no implant.  Similar studies 
suggested that enhancement in circulating IGF-I was a primary response to hormone 
implantation that could be attributed to increased animal growth and improvements in skeletal 
muscle accretion (Dunn et al., 2003; Frey et al., 1995; Kamanga-Sollo et al., 2004) 
 Implant effectiveness in enhancing animal growth is well documented.  Apple et al. 
(1991) reported that Holstein steers implanted with a TBA, zeranol, or combined EB and 
progesterone implant had higher average daily gains (ADG) for the first 56 d of implantation 
versus control steers. Similarly, Duckett et al. (1997) reported increases in ADG and dry matter 
intake (DMI) by feedlot steers given a single combined estrogen plus androgen implant.  
Additional literature shows that combination estrogen/TBA implants have an exacerbated effect 
on increased final body weight, ADG, DMI, and feed to gain ratio (F:G) compared to non-
implanted cattle or those subjected to single implant strategies (Apple et al., 1991; Bruns et al., 
2005; Duckett et al., 1997; Perry et al., 1991; Scheffler et al., 2003).  Studies also reported 
increased hot carcass weight (HCW) and LM area (LMA) compared to cattle receiving no 
implant, and inconsistent effects on 12
th
 rib fat thickness (FT) and yield grade (Apple et al., 
1991; Duckett et al., 1997; Perry et al., 1991; Scheffler et al., 2003). 
 While anabolic implants provide obvious benefit to live animal growth and carcass 
characteristics, their effect on carcass quality and beef tenderness have been questioned.  Platter 
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et al. (2003) reported that cattle receiving differing lifetime implant strategies had lower 
marbling scores than cattle receiving no implant.  The same study also reported a shift in the 
quality grade distributions of cattle, indicating a decrease in the frequency of carcasses grading 
upper two-thirds Choice and Prime using more aggressive implant strategies or a greater number 
of implants from weaning to finishing (Platter et al., 2003).  Similar results were reported by 
Roeber et al. (2000) for feedlot cattle, in which case a decrease in marbling score was observed 
when combination implants or implant/re-implant strategies were used.  Studies to determine 
effects of implants on tenderness have reported varied results.  Multiple studies have reported no 
difference in Warner-Bratzler shear force (WBSF) values between steaks from non-implanted 
control cattle versus those receiving different single or combination implants (Beirman et al., 
1999; Huffman et al., 1991; Milton and Horton, 1996); however, other studies have reported 
various implanting strategies having a deleterious effect on WBSF values compared to steaks 
from non-implanted cattle (Kerth et al., 2003; Pritchard et al., 2000; Roeber et al., 2000; Samber 
et al., 1996).  Likewise, consumer acceptance of tenderness from steaks from implanted cattle 
versus non-implanted report conflicting results (Kerth et al., 2003; Roeber et al., 2000). 
 Implants remain the most widely used form of growth promotion in growing and 
finishing beef cattle due to their effectiveness and ability to improve production efficiency.  
Beta-adrenergic agonists 
 Beta-adrenergic agonists are a multifaceted pharmacological agent utilized in both human 
medicine and livestock production.  In human medicine, βAA are used as a bronchodilator to 
treat asthma, and to stimulate cardiac contraction strength and rate (Hossner, 2005).  
Alternatively, βAA are used in livestock to stimulate skeletal muscle growth, increase live and 
carcass weight gains and improve efficiency in cattle and swine.  
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Evaluation of the use of βAA started to build momentum in the 1970’s and 80’s with the 
use of clenbuterol, cimaterol, L664,969, salbutamol and fenterol for use in livestock (Anderson et 
al., 2005; Mersmann, 1998).  However, these compounds were never given FDA approval for 
commercial use in food producing animals.  Clenbuterol is associated with adverse human health 
effects when tissues from those animals were consumed or inhalation of the compound during 
feed mixing.  Several public health issues were associated with clenbuterol residues through the 
1990’s; hence, the use of the substance and associated βAA’s were made illegal in the livestock 
industry.  Ractopamine hydrochloride and ZH are the only βAA approved for use in livestock in 
the United States.  Ractopamine (Paylean
®
; Elanco Animal Health, Greenfield, IN) was 
approved for use in swine in 1999, and later for cattle (Optaflexx
®
, Elanco Animal Health, 
Greenfield, IN) in 2003.  Zilpaterol (Zilmax
®
; Merk Corp., Summit, NJ) was approved for use in 
cattle for many years in South Africa and Mexico, and later received FDA approval for use in 
cattle in the United States in 2006. 
 The catecholamines epinephrine and norepinephrine serve as biological βAA’s in 
mammalian species, which bind to β-adrenergic receptors (βAR) to elicit a response on the 
sympathetic nervous system.  These are of primary interest to human medicine, as they relate to 
bronchodilation and effect cardiovascular function (Mersmann, 1998).  These hormones are 
inactivated and reabsorbed by specific uptake mechanisms to prevent the βAR from remaining 
active (Mersmann, 1998). 
 Beta-adrenergic agonists have the ability to bind to any of three βAR (β1-AR, β2-AR, or 
β3-AR) which are present in most mammalian cells, but are present in different concentration 
depending upon the tissue and specie (Johnson, 2004; Mersmann, 1998).  In skeletal muscle and 
lipid cells, β1-AR and β2-AR are the most common receptors, and have the greatest affinity for 
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pharmacological βAA (Mersmann, 1998).  These receptors are members of the Gs protein 
coupled receptors.  The βAR contain a seven membrane-spanning domain that forms loops on 
the cell membrane and are exposed on both the intra- and extracellular surface (Johnson, 2004).  
The physiological response to βAA is initiated when the βAA binds on the extracellular surface 
to the βAR, causing a conformational change to the receptor.  This activates adenylate cyclase to 
synthesize cyclic-adenosine monophosphate (cAMP) from adenosine triphosphate (ATP).  
Cyclic AMP regulates the activity of protein kinase A (PKA), which is responsible for the 
phosphorylation of necessary enzymes involved in lipid and protein synthesis, as well as 
regulation of DNA transcription factors (Anderson et al., 2005; Johnson, 2004).  Furthermore, 
PKA targets intracellular domains on the βAR to render it inactive. 
 In more general terms, βAA and the intracellular signaling cascade increases protein 
synthesis and decreases fat synthesis in livestock.  It is because of this that βAA’s are referred to 
as “repartitioning agents” due to repartitioning normal metabolic processes from synthesis of fat 
to synthesis of muscle.  Beta-adrenergic receptors present on fat cells decrease lipid synthesis 
and increase lipid degradation; likewise, βAR present on muscle cells elicit a response which 
increases protein synthesis and a decrease in protein degradation (Anderson et al., 2005).  When 
fed to ruminant livestock, it is suggested that the compound leaves the rumen intact, and is 
absorbed in the lower parts of the gastrointestinal tract; after which it enters the blood stream, is 
degraded in the liver, and is then delivered to the target tissues to elicit a response (Johnson, 
2004). 
Beta-Adrenergic Agonist Effects  
 It is widely understood that βAA supplementation improves live animal performance and 
efficiency, carcass weight and yield, and has negative effects on muscle tenderness and eating 
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quality.  Efficacy varies depending upon βAA-type, animal age, cattle biological type, and if it is 
used in combination with other growth promoting strategies. The following section will highlight 
research focusing on varying βAA’s used in cattle production and its effects on production traits 
and carcass characteristics. 
Live Animal Performance 
 There are a multitude of recent studies investigating RH and ZH effects on cattle growth.  
Gruber et al. (2007) reported RH supplementation at 200 mg/hd/d increased final BW, ADG, and 
G:F ratio of Brahman, Continental, or British influenced cattle.  Gruber et al. (2007), however, 
did not report a RH × breed effect, indicating that RH has no differential effect on cattle of 
differing biological types.  Likewise, Abney et al. (2007) reported that RH supplementation 
improved final BW, ADG, and G:F ratio.  Both Gruber et al. (2007) and Abney et al. (2007) 
indicated RH supplementation improved final BW by 7.3 and 5.9 kg, respectively; ADG was 
improved by approximately .2 kg/d.  Abney et al. (2007) also reported a RH feeding duration 
effect when fed for 28, 35, and 42 d.  Gains from RH supplementation were optimized at 35 d of 
feeding for final BW, ADG, and G:F ratio compared to shorter or longer feeding periods (Abney 
et al., 2007).  Vogel et al. (2009) reported similar results feeding RH to calf-fed Holstein steers.   
Comparatively, Quinn et al. (2008) reported minimal effects of treatment on live animal 
performance in feedlot heifers supplemented RH at 200 mg/hd/d.  Allen et al. (2009) reported 
results similar to Quinn et al (2008) that live performance was not effected when feeding market 
dairy cows RH at 312 mg/hd/d.  These results were attributed to the inherent variability 
associated with feeding market cows versus feedlot cattle that are more consistent in their 
biological type and age (Allen et al., 2009). 
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The majority of experiments assessing the effects of Zilpaterol on live animal 
performance have been conducted in the last five years due to the recent FDA approval for use in 
meat producing livestock.  Early research conducted in Mexico indicated advantages for growth 
and performance feeding ZH in comparison to cattle receiving none (Avendaño-Reyes et al., 
2006; Plascencia et al., 1999).  A growing body of literature from the United States indicates ZH 
supplemented feedlot cattle possess similar growth and performance characteristics to those fed 
RH.  A study published by Vasconcelos et al. (2008) reported minimal differences in final BW of 
steers supplemented ZH for the final 20, 30 and 40 d of finishing compared to steers fed no beta-
agonist.  The same study also reported that steers supplemented with ZH had significantly higher 
ADG and G:F ratio than steers fed no beta-agonist (Vasconcelos et al., 2008).  In a similar study 
that evaluated ZH supplementation and duration of feeding, Elam et al. (2009) indicated that ZH 
supplementation increased final BW and improved ADG and G:F ratio versus non-supplemented 
steers.  Elam et al. (2009) reported an 8, 9.3, and 10.8 kg increase in final BW when ZH is 
supplemented for the final 20, 30 and 40 d of the finishing period, respectively.  In addition, 
other studies reported improvements in ADG and G:F ratio due to dietary ZH supplementation 
(Beckett et al., 2009; Montgomery et al., 2009; Scramlin et al., 2010). 
Studies comparing efficacy of RH and ZH have resulted in varied results with respect to 
live animal growth and performance.  Avandaño-Reyes et al. (2006) reported that ZH 
supplementation improved final BW, ADG and G:F ratio of beef steers versus those 
supplemented RH.  Conversely, Scramlin et al. (2010) reported an advantage of 4.35 kg of final 
BW for RH supplemented beef steers over ZH supplemented steers, as well as increases in ADG 
and G:F ratio when supplemented with RH.  Strydom et al. (2009) indicated that RH 
supplementation imparted significant increases in ADG and G:F in beef steers versus those 
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supplemented ZH, while also reporting an numerical advantage in final BW, albeit not 
statistically significant. 
Carcass Characteristics 
Original research investigating effects of βAA focused primarily on the compounds 
clenbuterol and cimaterol.  Ricks et al. (1984) reported that cattle supplemented with with 
clenbuterol had lower 12
th
-rib FT, larger LMA, and lower numerical yield grade (YG).  The 
study also reported changes in overall carcass composition due to clenbuterol supplementation, 
indicating an increase in percent protein and a decrease in percent fat due to treatment (Ricks et 
al., 1984). 
 More contemporary studies that evaluated effects of RH supplementation on carcass 
characterisitcs indicates improvements in carcass cutability and yield.  Gruber et al (2007) 
reported an increase in HCW of 5.5 kg and larger LMA when steers were supplemented RH at 
200 mg/hd/d.  The results showed no difference in dressing percent, 12
th
-rib FT, or USDA YG 
(Gruber et al., 2007).  However, RH did increase the percentage of YG2 and decrease the 
percentage of YG3 carcasses (Gruber et al., 2007).  Likewise, RH did not affect the distribution 
of carcasses in respective USDA QG categories (Gruber et al., 2007).  In a study analyzing 
effects of RH fed at 200 and 300 mg/hd/d to calf-fed Holstein steers, a study by Vogel et al. 
(2009) generated results similar to those reported by Gruber et al. (2007).  Holstein steers that 
were supplemented with RH at 200 and 300 mg/hd/d had heavier HCW and larger LMA 
compared to control steers, while steers supplemented at 300 mg/hd/d had leaner 12
th
-rib FT 
(Vogel et al., 2009).  In addition, steers supplemented 300 mg/hd/d of RH had lower a lower 
calculated YG, while steers supplemented RH at 200 mg/hd/d had lower marbling scores and a 
lower percentage of carcasses grading USDA Prime and Choice (Vogel et al., 2009).  Similar 
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results were reported in studies comparing treatment with either RH or ZH (Avendaño-Reyes et 
al., 2006; Scramlin et al., 2010).  A more exhaustive body of literature indicates improvements in 
carcass traits and yield in swine supplemented with RH at varying doses and potencies (Apple et 
al., 2004; Armstrong et al., 2004; Uttaro et al., 1993; Watkins et al., 1990). 
 Zilpaterol supplementation in finishing beef cattle has proven to be highly effective at 
improving carcass composition and yield.  Vasconcelos et al. (2008) reported that ZH 
supplementation for the final 20, 30, or 40 d of finishing increased HCW, LMA, and decreased 
12
th
-rib FT and USDA YG in comparison to cattle receiving no βAA supplementation.  These 
results were consistent with other studies investigating the effects of ZH on carcass 
characteristics and were indicative of the normal response in ZH supplemented beef steers (Elam 
et al., 2009; Kellermeier et al., 2009; Rathmann et al., 2009).  A similar trend in improved HCW, 
LMA, and YG also were reported in calf-fed Holstein steers supplemented with ZH for differing 
lengths of time (Beckett et al., 2009; Garmyn et al., 2010).   
An effect of ZH treatment of fed cattle that is not reported in RH literature was an 
improvement in dressing percent.  Multiple studies reported a higher mean dressing percent in 
ZH fed cattle compared to controls, while also indicating a greater increase in HCW than in live 
weight (Beckett et al., 2009; Elam et al., 2009; Vasconcelos et al., 2008).  There is no literature 
which supports a likely hypothesis for the reason behind the differential partitioning of nutrients 
between fat and lean tissues.  Vasconcelos et al. (2008) reported a linear increase in lean tissue 
accretion with increased days of ZH supplementation with little variation in carcass fat between 
feeding periods.  Further research is necessary to determine reasons for the disparity in live and 
carcass weights, as well as to determine what causes increases in dressing percent recognized via 
ZH supplementation, but not by feeding RH. 
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 Carcass cutability and subprimal yields have been widely investigated in cattle 
supplemented with ZH, but there is currently no literature addressing differences in beef carcass 
yield due to RH supplementation.  Kellermeier et al. (2009) indicated an increase in subprimal 
yield from nearly all fabricated carcass subprimals compared to controls.  Carcass cutability 
studies analyzing both beef-type feedlot cattle and calf-fed Holsteins have reported increases in 
subprimal yield as well (Boler et al., 2009; Garmyn et al., 2010; Hilton et al., 2009; Rathmann et 
al., 2009).  These results indicate the additional value added for packers due to larger subprimals 
– specifically higher value cuts from the rib and loin – due to Zilpaterol supplementation.  The 
greatest effect of dietary ZH supplementation is recognized in cuts from the round (Shook et al., 
2009).  This is largely attributed to an increased concentration of Type IIa, glycolytic fibers, 
which are more responsive to βAA supplementation (Miller et al., 1988).  Along with this, a 
study analyzing carcass composition of steers and heifers receiving dietary ZH supplementation 
reported steers and heifers had an increase in soft tissue protein percentage and weight, as well as 
an increased protein to bone ratio (Leheska et al., 2009).  
 Supplementation of ZH also has been shown to not only negatively affect marbling score, 
but also to cause a shift in the distribution of USDA quality grades in feedlot cattle.  Kellermeier 
et al. (2009) reported a decrease in marbling score between ZH supplemented steers and controls 
of approximately 40 degrees.  More importantly though, when compared to controls, ZH 
supplementation decreased the frequency of carcasses grading Premium Choice by nearly 17 
percent (20% vs. 3.3%); decreased the percentage of carcass grading Choice by approximately 
13 percent (36.67% vs. 23.33%);  and increased the frequency of carcasses grading Select by 
nearly 20 percent (Kellermeier et al., 2009).  A study conducted by Vasconcelos et al. (2008) 
reported results consistent with those of Kellermeier et al. (2009), to the extent that ZH 
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supplementation for 20, 30, or 40 d decreased the frequency of carcasses grading Choice and 
Prime by 16.1, 18.4, and 22 percent, respectively; the frequency of carcasses grading Select 
increased by 8.2, 9.8, and 19.8 percent, respectively. Vasconcelos et al. (2008) also reported that 
mean marbling score decreased by 31.1, 46.0, and 54.4 degrees for each feeding period.  These 
results indicate that while ZH supplementation decreases marbling scores by less than half of a 
total marbling score, the deleterious effects on quality can drastically effect the distribution of 
carcasses receiving a quality based premium.  
Tenderness and Palatability 
 The largest detriment of βAA supplementation is likely to be the consequential reduction 
in beef tenderness.  A growing body of literature suggests that supplementation of βAA causes a 
decrease in objective tenderness measurements and are consistently rated less desirable by 
trained and consumer sensory panelists. 
 Studies to assess the effects of RH supplementation on postmortem tenderness have 
shown mixed results.  In a study in which RH was supplemented at 200 mg/hd/d for the final 28 
d of the finishing period, LM steaks from supplemented steers were on average 0.38 and 1.4 kg 
tougher for WBSF and SSF, respectively (Gruber et al., 2008).  Furthermore, the study reported 
that 3, 7, 14, and 21 d of post mortem aging did not diminish the effect of RH supplementation 
(Gruber et al., 2008).  The difference in tenderness was further recognized by trained sensory 
panelists, who rated steaks from RH supplemented cattle lower for tenderness and juiciness 
attributes (Gruber et al., 2008).  Scramlin et al. (2010) reported that RH supplementation 
increased WBSF values at 3 and 7 d aging versus steaks from control carcasses; however, the 
disparity in tenderness was negated at the 14 and 21 d aging interval.  These results agreed with 
Quinn et al. (2008) who reported no differences in WBSF values for LM steaks aged 14 d from 
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heifers supplemented 200 mg/hd/d of RH for the final 28 d of the finishing period.  Boler et al. 
(2012) reported that steers supplemented with RH at 200 mg/hd/d for the final 28 d of the 
finishing period produced LM steaks with WBSF values that differed from control steers only at 
4 d postmortem; however, steers receiving RH at 300 mg/hd/d for the final 28 d of the finishing 
period produced LM steaks that were tougher at 7, 14, and 21 d postmortem than both control 
and 200 mg/hd/d supplemented steers.  At 28 d postmortem aging, steaks from cattle in the 
control, 200, and 300 mg/hd/d treatments did not differ (Boler et al., 2012).  While these results 
vary, it appeared that increased post mortem aging for steaks from RH supplemented cattle 
provides the opportunity to mitigate negative effects on tenderness. 
 Zilpaterol supplementation in feedlot cattle has been shown to have more pronounced 
effects on beef tenderness.  Leheska et al. (2009) reported that carcasses of steers and heifers 
supplemented with ZH for the final 20 and 40 d of finishing generated LM steaks with greater 
WBSF values than controls after 28 d post mortem aging.  Zilpaterol supplementation for the 
final 20 d of finishing accounted for a 0.72 and 0.84 kg increase in WBSF in steers and heifers, 
respectively (Leheska et al., 2009).  Likewise, trained sensory panelists rated steaks from 
carcasses of ZH supplemented steers significantly tougher than controls; while LM steaks from 
carcasses of ZH supplemented heifers tended to be rated tougher by trained panelists (Leheska et 
al., 2009).  Rathmann et al. (2009) reported similar increases in WBSF values for steers fed 
dietary ZH for the final 20, 30, and 40 d of finishing.  Increased time of ZH supplementation 
increased WBSF at 7, 14, and 21 d post mortem aging, and WBSF values for all feeding and post 
mortem aging periods exceed those from control carcasses (Rathmann et al., 2009).  In the study 
conducted by Rathmann et al. (2009), a study by Miller et al. (2001) was cited for determination 
of tenderness thresholds.  Miller et al. (2001) determined that at a WBSF of < 3.0 kg, 100 percent 
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of consumers found New York Strip steaks to be acceptable for tenderness (Miller et al., 2001).  
The study also determined at a WBSF value of 4.3 kg, 86 percent of consumers found steaks 
acceptable, and that 4.9 kg was a major point of distinction from consumers between tough and 
tender steaks (Miller et al., 2001).  In the study published by Rathmann et al. (2009), frequency 
distributions for ZH vs. control treatments at each of the WBSF values referenced by Miller et al. 
(2001) showed that LM steaks from control carcasses had a significantly greater percentage of 
steaks at 3.0 and 4.3 kg of WBSF.  Similarly, steaks from each of the three ZH treatments (fed 
for 20, 30, and 40 d) had a significantly greater percentage of steaks at or above the 4.9 kg 
threshold for toughness (Rathmann et al., 2009).  Results from these studies are consistent with 
others that have evaluated tenderness from ZH supplemented cattle, and illustrate the profound 
effect dietary ZH has on postmortem tenderness and consumer acceptability (Avendaño-Reyes et 
al., 2006; Hilton et al., 2009; Kellermeier et al., 2009). 
Combined Growth Technology Strategies 
 Anabolic implants and βAA’s appear to enhance mammalian by independent mode of 
actions.  While estrogenic hormones impose their function on skeletal muscle via increases in 
GH and IGF-I and androgenic hormones directly affect muscle cells via androgen receptors, it is 
expected that βAA act through βA-receptors found locally on skeletal muscle and lipid cells and 
produce an intracellular signaling cascade which increases protein synthesis and decreases 
lipogenesis (Johnson, 2004; Trenkle, 1997).  Hence, it is hypothesized that independent 
responses would provide the opportunity to enhance growth to a degree that supersedes the 
normal response from implants or βAA individually.  
 Winterholler et al. (2008) compared steers receiving a combined TBA/E17β implant (120 
mg TBA and 24 mg E17β) to steers receiving the same implant strategy in addition to dietary RH 
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at 200 mg/hd/d for the final 37 d of finishing and reported that there were no differences in final 
BW between the two treatments.  Furthermore, while RH treated steers had a greater ADG for 
the final 37 d of finishing, ADG did not differ between treatments across the entire period on 
feed (Winterholler et al., 2008).  Carcass characteristics also indicated that dietary RH 
supplementation did not significantly affect HCW, LMA, or 12
th
-rib FT; however, USDA YG 
and marbling score were decreased in cattle receiving dietary RH supplementation (Winterholler 
et al., 2008).  Likewise, in a study published by Woerner et al. (2011), 73 steers and heifers 
received an initial TBA/E2 implant (80 mg TBA and 16 mg E2) at d 0 and a terminal TBA/E2
 
implant (120 mg TBA and 14 mg E2) at d 63 of feeding; the comparison treatment (n=74 steers 
and heifers) received the same two-implants strategy along with 200 mg/hd/d of dietary RH for 
the final 28 d of the finishing period (Woerner et al., 2011).  Results indicated that RH 
supplementation had no effect on final BW, while ADG was improved only during the period of 
RH supplementation; however ADG over the entire test was not affected by dietary RH 
supplementation.  Bass et al. (2009) reported that calf-fed Holstein steers administered differeing 
implanting strategies did not differ in final BW, ADG, HCW, or LMA compared to steers given 
identical implanting strategies in addition to 200 mg/hd/d of RH for the final 36 d of finishing. 
 Studies determining effects of ZH on beef steers, combined with various implant 
strategies have reported increases in live performance and carcass characteristics.  Baxa et al. 
(2010) reported that a combined ZH and implant regimen provided additive effects on carcass 
characteristics.  Steers fed dietary ZH (8.38 mg/kg (DM basis) for the final 30 d of the feeding 
period followed by a 3-d withdrawal before slaughter) in addition to a combined TBA/E2 implant 
(120 mg TBA and 24 mg E2) had the heaviest final BW, highest ADG and G:F ratio, the heaviest 
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HCW and largest LMA compared to steers only receiving the terminal implant, dietary ZH 
supplementation, or neither.   
 Research has been conducted to determine how both implants and βAA directly affect 
βA-receptors and IGF-I expression to determine reasons for disparities in growth enhancement.  
Multiple studies (Sissom et al., 2007; Baxa et al., 2010, Winterholler et al., 2007) reported 
increases in β2-AR mRNA due to both dietary RH and ZH supplementation which was nearly 
1,000 times greater than the concentration of β1-AR mRNA expression.  Literature suggests that 
RH has a selective affinity for β1-AR (Mills, 2003), whereas ZH has a higher affinity for β2-AR 
(Montgomery et al., 2009).  It is feasible that the increased β2-AR mRNA provides the impetus 
for an more pronounced growth response to dietary ZH used in combination with a hormone 
implant regimen compared to similar implant strategies using dietary RH.  Additionally, 
literature indicate that steroid hormones can act through nongenomic actions, in which hormones 
work through second messenger systems such as cAMP signaling, similar to RH (Falkenstein et 
al., 2000).  Estrogen administration also has been reported to reduce protein expression of the β1-
AR (Kam et al., 2004), which could mitigate RH responsiveness when used in combination with 
estrogenic implants. 
 Longissimus muscle tenderness also is affected due to combined implant/βAA strategies.  
Woerner et al. (2011) reported that steers and heifers supplemented with dietary RH in addition 
to a two-implant regimen generated LM steaks that were 0.23 kg tougher than at 28 d 
postmortem compared to those which did not receive dietary RH supplementation.  Kellermeier 
et al. (2009) reported steers receiving both dietary ZH supplementation and a combined TBA/E2 
terminal implant generated LM steaks that were 1.2 kg tougher for WBSF values compared to 
those receiving only the combined implant.  These negative additive effects of combined 
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implant/βAA strategies indicated the necessity for judicious use of growth enhancement 
technologies to mitigate the potential for reduction in consumer acceptance of retail product 
(Woerner et al., 2011). 
Physiological Effects of Beef Tenderness 
 While it is widely recognized that βAA have deleterious effects on beef tenderness, there 
are various theories on the physiological modes of action which effect post mortem tenderness. 
 A generally accepted theory for the effects of βAA on beef tenderness is an effect of 
changes in muscle fiber diameter.  Calkins et al. (1981) suggested that fiber type, and 
subsequently fiber diameter, is associated with beef tenderness.  Type I, β-red, or slow twitch 
oxidative fibers are understood to have a smaller fiber diameter and higher concentrations were 
more associated with improved muscle tenderness (Klont et al., 1998).  Likewise, Type IIa, α-
white, or fast twitch glycolytic fibers are understood to have a larger fiber diameter and an 
increased concentration of these fibers are more associated with negative tenderness attributes; 
Type IIx, α-red, or intermediate fast twitch oxidative glycolytic fibers are intermediate to Type I 
and Type IIa fibers in fiber diameter (Klont et al., 1998).  Research associating βAA with fiber 
type report a shift in fiber type, with decreased concentrations of Type I fibers and increased 
concentrations of Type II fiber types (Gonzalez et al., 2010; Gonzalez et al., 2009; Kellermeier et 
al., 2009).  Gonzalez et al. (2009) reported that the adductor, gracilis, Longissimus laborum, and 
vastus lateralis muscles decreased in Type I fiber concentration while increasing in Type II fiber 
concentration due to dietary RH supplementation.  However, the Type I and Type II fiber 
diameter was unchanged due to RH supplementation (Gonzalez et al., 2009).  Baxa et al. (2010) 
reported no changes in concentration of Type I and Type IIa fibers due to dietary ZH 
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supplementation; however, an increase in concentration of Type IIx fibers was reported in ZH 
supplemented steers.   
 Differential effects on proteolytic enzyme activity due to βAA supplementation also have 
been studied to determine their effects on post mortem tenderness.  The calpain system (m-
calpain and µ-calpain) is generally recognized to improve post mortem tenderness due to the 
degradation of structural proteins (Goll, 1991).  Likewise, calpastatin is an endogenous inhibitor 
of calpains, and increased concentration of calpastatin has been proven reduced beef tenderness 
(Goll, 1991).  Hilton et al. (2009) reported no effect on µ- or m-calpain activity or calpastatin 
activity in steers supplemented with dietary ZH.  Likewise, Rathmann et al. (2009) reported no 
effect on calpastatin mRNA abundance in steers supplemented dietary ZH.  Walker et al. (2010) 
also reported that calpastatin mRNA expression was not effected by dietary RH supplementation 
at 200 mg/hd/d at day 14 or 28 of the feeding period.  Studies which reported differences in 
calpain activity due to βAA supplementation involved supplementation of cattle with cimaterol, 
a βAA now banned by the FDA for use in livestock (Bardsley et al., 1992; Parr et al., 1992). 
 Considering the effect of βAA’s on the proteolytic enzyme system are negligible, 
extended postmortem aging periods should have minimal effect on disparities in tenderness 
associated with βAA treatments.  Gruber et al. (2008) reported that steaks from steers 
supplemented 200 mg/hd/d of dietary RH for the final 28 d of the feeding period had similar 
aging curves to steaks from control steers, and the difference in WBSF value between treatments 
was only slightly diminished from 3 to 21 d post mortem aging.  These results were similar to 
those of Woerner et al. (2011), who determined that the effect of RH on LM WBSF was 
unaffected by postmortem aging out to 28 d.  However, other studies evaluating the effect of 
postmortem aging on steaks from RH supplemented steers have reported that, while these steaks 
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had tougher WBSF values early in the postmortem aging period, by 21 d, the disparities in 
tenderness were largely diminished (Boler et al., 2012; Scramlin et al., 2010).  Scramlin et al. 
(2010) reported that while tenderness was improved after a 21 d aging period, WBSF values for 
steaks from ZH supplemented steers was still significantly tougher after postmortem aging.  
These results were supported in other ZH studies (Brooks et al., 2009; Kellermeier et al., 2009; 
Rathmann et al., 2009), and indicated that, while the differences in tenderness between steaks 
from ZH supplemented steers and controls is diminished, ZH steaks are still considerably 
tougher after 21 d post mortem aging.  Garmyn et al. (2010) determined that at a tenderness 
threshold of 4.6 kg WBSF, 100 percent of steaks from steers receiving no βAA supplementation 
were under the threshold value at 7, 14, 21, 28, and 35 d post mortem; by 35 d post mortem, 100 
percent of steaks from ZH supplemented steers were also under the 4.6 kg threshold.  More 
research is needed to evaluate the influence of extended postmortem aging periods on tenderness 
improvement for beef cattle supplemented with βAA past 21 d of aging. 
 Additional areas of research to determine βAA effects on postmortem tenderness have 
evaluated protein accretion and degradation.  Proteins are continually degraded in skeletal 
muscle in the living animal, and rate of protein degradation versus protein accretion is related to 
an animal’s ability to undergo muscle hypertrophy (Wheeler and Koohmaraie, 1992).  Early 
research using the βAA L644,969 reported that muscle protein degradation was only reduced after 3 
weeks of supplementation, however, muscle protein accretion was increased after 1, 3, 5, and 6 
weeks of supplementation (Wheeler and Koohmaraie, 1992).  More contemporary studies agree 
with these findings, and have indicated that βAA supplementation has a greater effect on protein 
accretion compared to protein degradation (Gonzalez et al., 2008; Kellermeier et al., 2009; 




 Growth enhancement technologies have been widely embraced in the livestock industry 
to improve growth, efficiency, and carcass traits.  While hormonal implants have been utilized 
for decades in cattle production, recent advancements in dietary βAA supplements have offered 
swine and cattle producers the opportunity to further improve their production efficiency.  
Implanting strategies utilized intermittently during the growing and finishing phases in feedlot 
cattle have been reported to increase live weight, ADG, and feed efficiency, while also 
improving HCW, LMA, and FT (Apple et al., 1991; Bruns et al., 2005; Duckett et al., 1997; 
Perry et al., 1991; Scheffler et al., 2003).  Likewise, dietary supplementation of βAA’s has been 
shown to also improve live animal growth and have more profound effects on carcass traits and 
carcass cutability (Allen et al., 2009; Gruber et al., 2007; Hilton et al., 2010; Kellermeier et al., 
2009; Leheska et al., 2009; Rathmann et al., 2009; Scramlin et al., 2010; Vasconcelos et al., 
2008).  However, the improvements in growth and carcass traits are accompanied by reduction in 
marbling score, and have been reported to reduce the frequency of carcasses qualifying for 
premiums in quality based grid marketing (Kellermeier et al., 2009; Vasconcelos et al., 2008). 
Furthermore, the most profound negative effect of both RH and ZH supplementation has been to 
reduce postmortem tenderness (Avendaño-Reyes et al., 2006; Gruber et al., 2008; Leheska et al., 
2009; Quinn et al., 2008; Rathmann et al., 2009; Scramlin et al., 2010). 
 Growth enhancement technologies offer a tremendous amount of potential to cattle 
feeders, yet judicious use is required to mitigate deleterious effects on postmortem beef quality 
and eating quality.  Further research is necessary to fully understand the physiological effects on 
beef tenderness.  However, matching the biological type of cattle that are inherently more tender 
with βAA supplementation is vital to upholding consumer acceptance of beef from aggressive 
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growth promoting strategies.  Cattle which inherently produce higher quality carcasses and more 
tender beef (e.g. greater British breed influence) are ideal subjects for more aggressive growth 
enhancement regimens.  Similarly, faster growing breeds that produce inherently tougher beef 
(e.g. greater Continental or Brahman influence) should be limited to less aggressive implanting 
and dietary βAA supplementation as this can impart additive effects on increasing beef 
toughness. 
 Hormonal implants and βAA are, and will continue to be widely used in the cattle feeding 
industry.  While their effectiveness is undeniable, optimizing animal growth, carcass traits, and 







EFFECT OF DIETARY BETA-AGONIST SUPPLEMENTATION ON LIVE 
PERFORMANCE, CARCASS CHARACTERISTICS, CARCASS FABRICATION YIELDS, 
AND STRIP LOIN TENDERNESS AND SENSORY TRAITS 
 
Materials and Methods 
A study was conducted at a commercial feed yard in the Panhandle of Texas in which 
approximately 4,000 head of British × Continental crossbred steers were allocated to one of five 
experimental feeding treatments to determine the effect of beta-adrenergic agonist (βAA) 
supplementation on live animal performance, carcass characteristics, fabricated carcass 
subprimal yield, and strip loin tenderness and palatability. 
Live Animal Phase 
Upon initial receiving at the commercial feed yard, cattle were individually weighed, ear 
tagged with a unique individual identification, vaccinated with a modified live virus vaccine 
(Titanium
®
 3, Agri Labratories, St. Joseph, MO) and a clostridial bacterin toxoid (Vision
®
 7 with 
SPUR, Merck Animal Health, Summit, NJ), treated for internal parasites (Ivomec Plus
®
, Merial, 
Duluth, GA), and treated metaphlactically with Micotil
®
 (Elanco Animal Health, Greenfield, IN).  
Steers also received an initial Component
®
 TE-IS with Tylan (16 mg estradiol and 80 mg TBA; 
Elanco Animal Health, Greenfield, IN) or Ralgro
®
 (26 mg Zeranol; Merck Animal Health, 
Summit, NJ) at initial processing, depending upon projected endpoint.  At approximately 90 d 
before projected slaughter date, all steers were re-implanted with a Component TE-S implant (24 
mg estradiol and 120 mg TBA; Elanco Animal Health, Greenfield, IN). 
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Approximately 60 d before the projected slaughter date, steers were transported from the 
commercial feeding facility to the company’s research feed yard, also in the Texas Panhandle.  
Upon arrival, steers were provided access to drinking water and a moderate-concentrate mixed 
diet.  The mean weight of steers upon arrival at the research feed yard was 484.6 ± 18.5 kg.  
Steers were weighed individually and ultrasonic carcass measurements were collected to 
determine projected terminal endpoint.  This information was used to allocate 3,906 steers into 
four separate slaughter groups (blocks).  Within each of the 4 blocks, cattle were randomly 
allocated to one of 5 treatment groups including: a negative control of cattle receiving no βAA 
(CON); cattle continuously fed 200 mg/hd/d of Ractopamine hydrochloride (RH; Optaflexx
®
, 
Elanco Animal Health, Greenfield, IN) for the final 30 d of the finishing period (RAC200); cattle 
continuously fed 300 mg/hd/d of RH for the final 30 d of the finishing period (RAC300); cattle 
continuously fed 400 mg/hd/d (top dress) of RH for the final 30 d of the finishing period 
(RAC400); and cattle fed Zilpaterol hydrochloride (ZH; Zilmax
®
, Merck Animal Health, 
Summit, NJ) at 6.8 g/ton of feed starting 23 d before slaughter and withdrawn 3 d before 
slaughter (ZIL).  Within each block, each treatment was replicated twice (2 
pens/treatment/block).  In total, 40 pens of approximately 100 hd/pen were utilized for the trial. 
Steers were immediately placed on a finishing ration after pen allocation.  Block 1 steers 
were placed on to trial on January 31
st
 and February 8
th
; block 2 steers were placed on trial 
February 9
th
; block 3 steers were placed on trial on February 21
st
 and March 5
th
; and block 4 
steers were placed on trial March 13
th
 and March 21
st
.  Detailed information on pens and dates of 
trial initiation are located in Appendix A.  Steers were tagged with an identical pen identification 
tag before being allocated to treatment pen.  Diets were formulated to meet or exceed National 
Research Council (1996) requirements for growing-finishing beef cattle at the research feed 
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yard’s feed mill.  Basal diets were mixed daily at the feed yard.  Rations were mixed to contain 
39.45% flaked corn, 25.18% dried distillers grains, 22.27% sweet bran blend, 7.01% corn silage, 
2.50% cotton seed hulls, 2.08% tallow, and 1.60% water on a dry matter basis.  Diets were 
formulated to contain the following nutrient dry matter composition: 73.92% dry matter, 16.94% 
crude protein, 21.14% crude fiber, and 8.00% fat.  All cattle were fed their respective diets twice 
daily at 0700 and 1300 h.  For steers receiving the RH treatments, a premix was included in the 
finishing ration to deliver 200 and 300 mg/hd/d for the final 30 d of the finishing period.  Cattle 
receiving the RAC400 treatment were fed a portion of the basal ration at initial feeding, after 
which the remainder of the basal ration was delivered 30 min later, formulated to deliver 400 
mg/hd/d of RH in an additional 2.5 kg/hd of feed.  Diets were formulated on a dry matter (DM) 
basis to include 18.18 g/ton RH for the RAC200 treatment, 27.28 g/ton RH for the RAC300 
treatment, 191.39 g/ton RH in the top dress for the RAC400 treatment, and 8.0 g/ton ZH for the 




 (Elanco Animal Health, Greenfield, IN) 
were added to basal diets at 30.0 and 8.0 g/ton DM, respectively.  Diet samples were 
intermittently obtained directly from the feed bunks during the morning feeding.  A portion of 
each sample was oven-dried at 100°C to monitor DM, while the remaining portion were retained 
and stored in a freezer.  Retained samples were composited and submitted to a commercial 
laboratory for analysis of RH and ZH inclusion rates. 
An employee from the research feedlot observed each pen of cattle daily during the study 
to assure proper functioning of water tanks, fences, and feed bunks.  Cattle behavior also was 
noted during the study (i.e., bulling, appetite, health).  Any sick or removal animals that did not 
return to the home pen within 24 h were removed from the study.  Any steers that died during the 
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duration of the study were necropsied by a trained feed yard employee according to normal feed 
yard procedures.  A list of removed and dead animals can be found in Appendix B.  
Before initiation of the treatment period, pen weights were collected in the morning 
before feeding for each treatment replicate between 0400 and 0700 h.  Weights for all treatments 
were collected on the same day; thus ZIL treatment pens were weighed eight days before ZIL 
treatment initiation.  A weight was collected for each pen, after which steers were returned to 
their home pens and their respective treatment was delivered.  Final pen weights were collected 
on the morning each block was shipped to slaughter.  Cattle were fed their respective treatment 
diet, weighed, and subsequently loaded on to 15.2 × 2.5 m pot-belly trailers for transport to a 
commercial processing facility.  Specific dates for treatment allocation, initiation, and shipment 
date can be found in Appendix A.  
Harvest and Carcass Phase 
 Cattle were shipped to a commercial beef processing facility in the Texas Panhandle in 
four blocks beginning on April 18
th
, 2012 for four consecutive wk. Steers were harvested during 
the second plant shift on each Wednesday during the plant phase.  Cattle were harvested using 
standard U.S. beef industry practices and USDA/FSIS inspection criteria.   
Each treatment pen was harvested consecutively during the shift and the first and last 
carcass from each pen was identified and traced to an individual plant sequence number that was 
maintained throughout carcass data collection.  Hot carcass weights (HCW) were automatically 
recorded by the plant at the end of the harvest line.  Carcasses were tracked throughout the 
harvesting process and any rail-ins/rail-outs were recorded so as to maintain sequence 
traceability.   
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 Carcasses were chilled for approximately 36 h.  After carcasses were thoroughly chilled, 




 ribs by plant personnel.  Carcass data were 
collected from the in-plant carcass imaging system and was downloaded from the plant database.  
Carcass data that was collected included: Longissimus muscle area (LMA), 12
th
-rib fat thickness 
(FT), marbling score, and USDA yield and quality grade (YG; QG).  Dressing percent (DP) for 
each pen was calculated by dividing the pen average of HCW by the pen live weight, and 
multiplied by 0.96 to represent a standard 4.0% pencil shrink. 
Carcass Fabrication and Subprimal Yield 
Carcasses were subsampled each week for whole carcass fabrication to determine 
subprimal yield.  Before grading, the mean HCW for each pen was calculated and carcasses were 
identified that were ± 30 pounds from the pen HCW mean.  During grading, two carcasses per 
pen within the given weight range were selected for each of four different fat thicknesses, 
including: Lean (< 0.32”); Low Average (0.33-0.44”); High Average (0.45-0.60”); and Fat (> 
0.60”).  The carcass fabrication selection matrix is listed in Appendix C.  This resulted in eight 
carcasses per pen, 16 carcasses per treatment, 80 carcasses per week, and 320 carcasses over the 
duration of the study.  Carcasses were fabricated during a separate shift each Saturday of the 
carcass phase.  Trained plant personnel fabricated carcass primals and individual components 
were weighed and recorded by Colorado State University personnel, whom assured that each 
subprimal calculated a weigh back yield that did not exceed ± 2% of the total (98 to 102%).  
Each side was separated into the components listed in Appendix C.  Weights were expressed as a 
percentage of chilled side weight, which was ascertained immediately before fabrication. 
Warner-Bratzler and Slice Shear Force 
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Eighteen samples per pen were randomly selected during grading.  The subsampling 
resulted in 36 samples per treatment per week, 180 samples per week, and 720 total samples over 
the duration of the study.  Strip loin samples were cut from carcasses after grading and 
transported to Colorado State University in coolers chilled with ice.  Samples were collected 
from both carcass sides; one side was used for shear force evaluation and the opposite was 
utilized for sensory evaluation.  Side selection was randomized to represent an equal number of 
left and right carcass sides for tenderness and sensory evaluation.  Upon arrival at the Colorado 
State University meat laboratory, the vacuum-sealed strip loin samples were aged for 14 d and 
subsequently frozen at -20°C.  Once fully frozen, samples were cut into 2.5 cm steaks on a band 
saw, vacuum packaged and replaced into frozen storage.  Upon conclusion of aging, samples 
were randomly assigned to a cooking day upon which Warner Bratzler Shear Force (WBSF) and 
Slice Shear Force (SSF) analysis was conducted.  Steaks were thawed at 4°C for 24 h and 
cooked on an XLT Impingement Oven (BOFI Inc, Wichita, KS).  A pre-cook temperature and 
weight, and post-cook temperature and weight were recorded.  Steaks were cooked to a medium-
well degree of doneness (68-71° C).  A 1 cm slice was removed parallel to the longitudinal 
direction of the muscle fibers from the anterior portion of a freshly cooked steak for SSF 
evaluation.  The measurement of SSF was conducted according to Shackelford et al. (1999) on 
an Instron Universal Testing Machine, Model 1011 (Instron Corporation, Canton, MA) using a 
slice shear force head at a cross-head speed of 500 mm/min.  The remaining portion of the steak 
was allowed to cool to room temperature after which a minimum of five, 1 cm cores were 
removed parallel to the longitudinal orientation of the muscle fibers for WBSF analysis.  Warner 
Bratzler shear force analysis was conducted according to AMSA guidelines (1995) on an Instron 
Universal Testing Machine, Model 1011 (Instron Corporation, Canton, MA) with a Warner-
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Bratzler shear head at a cross-head speed of 200 mm/min.  The core force for each of the 5 cores 
per steak was averaged to determine a single shear value for each steak. 
Trained Sensory Panel Evaluation 
Strip loin samples (720 total were subsampled) were collected from the opposite carcass 
side of carcasses selected for shear force evaluation.  Steaks were aged, frozen, cut, and stored 
identically to steaks for WBSF and SSF evaluation.  Twelve steaks were randomly assigned to 
one of 60 panels.  Three panels were served per day to a minimum of six trained panelists.  
Steaks were cooked on an XLT Impingement Oven (BOFI Inc, Wichita, KS) to a medium-well 
degree of doneness (68-71°C).  Steaks were then cut into 1 cm cubes, and two warm cubes per 
steak were fed to panelists.  Panelists rated each steak by making a mark on a 15 cm unstructured 
line scale for the following attributes: myofibrillar tenderness, connective tissue tenderness, 
overall tenderness, juiciness, beef flavor intensity, butter/beef fat flavor, and any perceived off-
flavors.  Each line scale indicated a very low presence or desirability on the far left side and very 
high presence or desirability on the far right.  A sample sensory ballot can be found in Appendix 
D.  For each sample, panelist scores were averaged to determine a single value for each attribute. 
Statistical Analysis 
Analysis was conducted as a completely randomized block design.  All variables were 
analyzed as a mixed model in JMP 9.0 (SAS Inst. Inc., Cary, NC) using pen as the experimental 
unit.  Block (slaughter week) and treatment were utilized as a fixed effect in the model.  The 
Student’s t-test was used to test for differences among least squares means when the main effect 
of treatment was significant at a P-value less than 0.05. 
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For subprimal yield data, any carcasses that had a subprimal yield that exceeded the ± 2% 
weigh-back yield threshold were removed from the dataset before analysis.  Subprimal yield was 
calculated as a percent of CSW.   
Results and Discussion 
Study Diet and Supplement Inclusion 
 Feed samples were collected and assayed regularly throughout the study for RH and ZH 
inclusion rates.  Assay results indicated that RH inclusion rate averaged 13.5, 22.4, and 124.2 
g/ton on an as fed basis for RAC200, RAC300, and RAC400 treatments, respectively. These 
samples averaged 108.9, 105.3, and 92.7% of the mean theory for RH inclusion on an as fed 
basis (acceptable limits are 75 to 125 percent).  Results from ZH assays indicated that the 
average inclusion rate was 6.36 g/ton on an as fed basis, which averaged 93.33 percent of the 
mean theory (acceptable limits are 75 to 115 percent).  Average per head consumption of RH for 
the CON and RAC treatments were 0, 192, 292, and 392 mg/hd/d.  Average per head 
consumption of ZH for the ZIL treatment was 80 mg/hd/d. 
Live Animal Performance 
Live animal performance data are listed in Table 3.1.  Upon initiation of the treatment 
phase, the average pre-treatment weight for all cattle on trial was 542.29 ± 2.72 kg, and did not 
differ among treatments (P = 0.9164).  There was no effect on final BW due to treatment (P = 
0.2892; Table 3.1).  Average daily gain was affected by treatment (P < 0.05), and was improved 
via dietary supplementation of βAA.  There were no differences between ZIL and all RAC 
treatments.  The RAC200 treatment did not differ from controls.  Dry matter intake was not 
affected by treatment (P = 0.0575), but tended to be decreased due to βAA supplementation.  As 
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such, F:G ratio was improved due to treatment (P < 0.05), and was significantly lower for ZIL 
and all RAC treatment versus controls. 
Present results were consistent with those of previous studies that revaluated the impact 
of RH and ZH supplementation.  These studies reported substantial improvements in live animal 
performance due to dietary βAA supplementation (Avendaño-Reyes et al., 2006; Boler et al., 
2012; Elam et al., 2009; Gruber et al., 2007).  In a comparative study between the two βAA 
compounds, Scramlin et al. (2010) reported similar advantages in final BW and ADG for cattle 
supplemented with 200 mg/hd/d of RH for the final 33 d of feeding compared to those receiving 
75 mg/hd/d of dietary ZH for 30 d; the study reported no differences in average daily feed intake 
or G:F ratio between the two βAA treatments (Scramlin et al., 2010).  Alternatively, Avendaño-
Reyes et al. (2006) reported conflicting results, reporting that steers supplemented with 60 
mg/hd/d of ZH for 30 d had larger final BW and greater ADG than steers supplemented 300 
mg/hd/d of RH for the same period.  Results from the current study showed negligible 
differences in final BW, and ADG and F:G values indicated negligible differences between RH 
supplemented at any level compared to ZH. 
Carcass Characteristics 
 Carcass results are summarized in Table 3.2 and 3.3.  Hot carcass weight differed by 
treatment (P < 0.05).  Increased dose and potency of βAA increased HCW, with ZIL treatment 
carcasses resulting in the heaviest HCW, which was similar to the RAC400 treatment.  Dressing 
percent also was improved due to treatment with ZIL treatment cattle reporting a higher DP 
compared to all other treatments (P < 0.05); steers receiving the RAC300 and RAC400 treatment 
had a similar DP to steers receiving the CON treatment.  Control steers and RAC200 steers 
generated carcasses with a similar DP.  Mesenteric fat weights were measured to aid in 
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quantification of disparities in DP.  There were no differences in mesenteric fat weights between 
treatments (P = 0.8429).  Current βAA literature recognizes improvements in HCW due to 
dietary βAA supplementation, as well as the improvements in DP provided by ZH 
supplementation (Avendaño-Reyes et al., 2006; Elam et al., 2009; Gruber et al., 2007; Scramlin 
et al., 2010; Vogel et al., 2009).  Current theories suggest a shift in protein metabolism from non-
carcass components to carcass components (i.e., kidney, pelvic, heart fat, organ weight, and 
mesenteric fat); however, there are no studies which report differences to substantiate differences 
in dressing percent.   
 Longissimus muscle area differed due to treatment (P < 0.05), and was largest for 
carcasses from steers treated with ZIL compared to all other treatments.  Steers receiving the 
RAC400 and RAC300 treatments had similar LMA, and were larger than steers receiving the 
RAC200 and CON treatments.  There were no differences in 12
th
-rib FT between treatments (P = 
0.8631).  It is generally recognized that both RH and ZH impart improvements on LMA in fed 
cattle (Avendaño-Reyes et al., 2006; Gruber et al., 2007; Kellermeier et al., 2009; Vogel et al., 
2009; Woerner et al., 2011).  However, previous studies have generated differing results on 
effects of βAA supplementation on FT and PYG.  Scramlin et al. (2010) reported that carcass FT 
was not affected by RH supplementation at 300 mg/hd/d for the final 33 d of the feeding period; 
however ZH supplementation at 75 mg/hd/d for the final 33 d of the feeding period decreased 
carcass FT in the same study compared to RH and control treatment cattle.  Vogel et al. (2009) 
reported that FT did not differ between controls and steers fed RH at 200 mg/hd/d for final 28 to 
38 d of the feeding period; yet, steers supplemented RH at 300 mg/hd/d for the final 28 to 38 d of 
the feeding period generated carcasses with reduced 12
th
-rib FT compared to controls and cattle 





(Elam et al., 2009; Hilton et al., 2009); however several studies also have reported no effect on 
carcass FT due to ZH supplementation (Kellermeier et al., 2009; Montgomery et al., 2009; Parr 
et al., 2011).  Supplementation level and duration of feeding of ZH was similar in each study, 
and there is little scientific information available to explain differences in carcass FT results. 
 USDA yield grade was improved due to treatment (P < 0.05; Table 3.2), and was lowest 
for carcasses from steers in the ZIL treatment compared to controls (2.70 vs. 2.98).  USDA yield 
grade was similar for all RAC treatments.  Treatment affected the frequency of YG1 and YG3 
carcasses (P < 0.05; Table 3.3; Figure 3.2).  Zilpaterol treatment of steers resulted in carcasses 
that were graded most frequently as YG1, and was a significantly higher frequency compared to 
all other treatments.  Likewise, steers receiving ZH supplementation had the lowest frequency of 
YG3 carcasses (P < 0.05), and was a lower frequency compared to all other treatments.  Gruber 
et al. (2007) reported a decrease in the frequency of YG3 and an increase in the frequency of 
YG2 carcasses due to RH supplementation.  Comparatively, Boler et al. (2012) reported no 
difference in YG distribution due to dietary RH supplementation.  Montgomery et al. (2009) 
reported that dietary ZH supplementation increased the frequency of carcasses with a numerical 
YG of 1.00-1.99 and 2.00-2.49, while also decreasing the frequency of carcasses with a 
numerical YG of 3.50-3.99 and 4.00-4.99.  The results from Montgomery et al. (2009) are 
consistent with Elam et al. (2009) who reported increases in carcasses with a numerical YG less 
than 2.5, and a decrease in the frequency of carcasses with a numerical YG greater than 3.5. 
 Marbling score for carcasses differed by treatment (P < 0.05; Table 3.2) and was lower 
for steer receiving the ZIL treatment compared to steers in the control treatment (407.50 vs. 
429.01).  As a function of this, the frequency of carcasses qualifying for an Upper 2/3 Choice 
premium was decreased due to treatment (P < 0.05) and there was a tendency for the frequency 
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of USDA Choice carcasses to be decreased due to treatment (P = 0.0973) with steers receiving 
the ZIL treatment generating the lowest frequency (46.85%); treatment also had a tendency to 
increase the frequency of USDA Select carcasses (P  = 0.1076), with steers receiving the ZIL 
treatment also having the highest frequency (50.43%).  There was no treatment effect on carcass 
maturity (carcasses exceeding C-maturity; P = 0.4555) or on carcasses receiving a discount for 
heavy HCW greater than 950 lbs. or greater than 1050 lbs. (P = 0.4448 and 0.7283, respectively).  
Marbling score distributions for each treatment also are reported in Appendix E.  Multiple 
studies have reported no difference in marbling score and quality grade distribution due to 
dietary RH supplementation of the live cattle from which these carcasses were derived (Boler et 
al., 2012; Gruber et al., 2007).  However, Vogel et al. (2009) reported a reduction in marbling 
score and a reduction in the frequency of Holstein steers grading USDA Prime and Choice as 
well as an increase in the frequency of steers grading USDA Select due to RH supplementation 
of the live cattle.  Studies assessing effects of dietary ZH supplementation on carcass quality 
have produced consistent results indicating a reduction in marbling score and general shift in the 
quality grade distribution to a higher frequency of carcasses grading USDA Select and a lower 
frequency of carcasses grading USDA Prime and Choice (Beckett et al., 2009; Elam et al., 2009; 
Montgomery et al., 2009). 
Carcass Subprimal Yield 
 Effects of treatment on carcass fabrication yields are listed in Table 3.4.  Total saleable 
yield differed by treatment (P < 0.05), and was highest for steers receiving the ZIL and RAC400 
treatments.  There were no differences between RAC200, RAC300, and RAC400 treatments.  
Likewise, total saleable yield was similar for steers receiving the CON, RAC200, and RAC300 
treatments.  The primary subprimals that were affected by treatment were located in the round 
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and sirloin.  Treatment with βAA increased yield for the inside round, eye of round, shank meat, 
peeled knuckle, outside round, tri-tip, and quadriceps muscle group (ball-tip + peeled knuckle).  
Additionally, the strip loin, 91’s trim, and bone differed by treatment (P < 0.05).  All subprimals 
that had a significant treatment effect did not differ between steers that received the ZIL or 
RAC400 treatments, with the exception of the inside round; steers receiving the CON and 
RAC200 treatments did not differ for any subprimal yields.  Likewise, all subprimals that 
differed by treatment had higher yields for subprimals derived from steers receiving the ZIL 
treatment compared to those receiving the CON treatment.  
Various cutout studies evaluating the effects of ZH supplementation on carcass cutability 
have produced similar results as those in the current study, and have reported the most 
pronounced yield effect on subprimals from the round (Hilton et al., 2009; Kellermeier et al., 
2009; Rathmann et al., 2009).  Yield increases in the round have been primarily attributed to a 
higher portion of Type IIa, glycolytic fibers in the round that are more responsive to βAA effects 
(Miller et al., 1988).  Rathmann et al. (2009) reported more pronounced effects of ZH 
supplementation compared to carcasses from control treatment steers on subprimal yield in the 
chuck with increases in the #114C chuck shoulder clod, #114F chuck shoulder tender, #116A 
chuck roll, and #116B chuck mock tender.  Comparatively, Hilton et al. (2009) and Kellermeier 
et al. (2009) only reported subprimal yield differences in the shoulder clod and mock tender, 
which are consistent with the results from the current study.  In comparison to studies conducted 
evaluating carcass cutout yield, carcass fabrication was conducted in large scale production 
facilities at faster line speeds, rather than at university meat laboratories; the subprimals were cut 
to plant specifications, rather than National Association of Meat Processors (NAMP) 
specifications or International Meat Purchasing Specifications (IMPS).  While the 
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aforementioned studies yielded similar results to the current, differences in subprimal yield could 
be attributed to different cut specifications.  Additionally, Rathmann et al. (2009), Hilton et al. 
(2009), and Kellermeier et al. (2009) pre-selected cattle and carcasses to represent uniform yield 
grade parameters for each treatment.  The current study utilized a selection criterion which sorted 
carcasses into four different fat thickness groups for each treatment.  Disparities in fat thickness 
could account for over-trimming of lean cuts and under-trimming of fatter cuts during normal in-
plant fabrication processes, which could decrease differences between subprimals in the current 
study compared to those that are recognized in studies conducted outside large-scale beef 
production facilities. 
Warner-Bratzler and Slice Shear Force 
 Results for objective tenderness evaluation are reported in Table 3.5.  Warner-Bratzler 
shear force values differed by treatment (P < 0.05) and increased with increased dose and 
potency of βAA.  Steaks from carcass of steers receiving ZIL treatment reported the highest 
WBSF values (3.95 kg) and were higher than all other treatments (P < 0.05).  Warner-Bratzler 
shear force values were similar for RAC300 and RAC400 treatments, while WBSF for steaks 
from steers receiving RAC200 and CON treatments also were similar.  The American Society for 
Testing and Materials (ASTM) has determined the WBSF threshold for tenderness claims in beef 
is 4.4. kg (ASTM, F2925-11).  The percentage of steaks with a WBSF value exceeding 4.4 kg 
increased due to treatment (P < 0.05).  The percentage of steaks shearing greater than 4.4 kg was 
nearly 20 percent greater in steaks from ZIL treatment carcasses compared to controls (22.34% 
vs. 2.50%).  Steaks from steers receiving RAC200, RAC300, and RAC400 treatments had 
similar frequencies of steaks shearing greater than 4.4 kg. 
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 Slice shear force values also differed by treatment (P < 0.05).  Steaks from steers 
receiving the ZIL treatment had the highest SSF values, while steaks from steers receiving the 
RAC300 and RAC400 treatments were not different; steaks from steers receiving the CON and 
RAC200 treatments did not differ, as well.  Similar to WBSF values, the ASTM SSF threshold 
for tenderness claims is 20.0 kg (ASTM, F2925-11).  At this threshold, frequency of steaks 
shearing greater than 20.0 kg differed by treatments (P < 0.05).  Steaks from steers receiving the 
ZIL treatment exceeded those from the control treatment that sheared greater than 20.0 kg by 
nearly 20 percent (25.10% vs. 5.66%); steaks from steers receiving the ZIL treatment also did 
not differ from steaks from steers receiving the RAC400 treatment.  There were no differences 
between steaks from steers receiving RH supplementation at any dosage. 
 A multitude of studies have reported the negative effects of dietary βAA supplementation 
on postmortem tenderness (Boler et al., 2012; Gruber et al., 2008; Leheska et al., 2009; 
Rathmann et al., 2009).  The current study evaluated tenderness only at 14 d postmortem and 
generated results similar to studies evaluating steaks from treated cattle at comparable aging 
periods.  Ractopamine studies have reported that at 14-d steaks from RH supplemented cattle are 
tougher than controls (Boler et al., 2012; Gruber et al., 2008; Scramlin et al., 2010; Woerner et 
al., 2011); however there is literature that suggests postmortem aging in excess of 14 d reduces 
disparities in tenderness (Boler et al., 2012; Scramlin et al., 2010).  Other studies have reported 
no effect of aging on improving tenderness in steaks from RH supplemented cattle compared to 
controls (Gruber et al., 2008; Woerner et al., 2011).  Studies evaluating dietary ZH 
supplementation on postmortem tenderness have reported more pronounced reductions in 
tenderness, and showed no effect of postmortem aging on reducing tenderness differences 
compared to controls (Garmyn et al., 2010; Kellermeier et al., 2009; Rathmann et al., 2009). 
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 There were no differences between treatments or contrasts in the percentage cook loss 
from steaks of carcasses used for objective tenderness measurements (Table 3.5). 
Trained Sensory Panels 
 Results for trained sensory panel analysis are reported in Table 3.6.  Each of the three 
tenderness attributes evaluated by trained panelists differed by treatment (P < 0.05).  Steaks 
derived from steers receiving the CON treatment were the highest rated for myofibrillar, 
connective tissue, and overall tenderness and steaks from steers receiving the ZIL treatment were 
the lowest rated for all tenderness attributes.  There were no differences between steaks from 
steers receiving the RAC400 treatment and ZIL treatment for connective tissue or overall 
tenderness; the two treatments did differ in the trained panelist ratings for myofibrillar 
tenderness.  There were no differences between steaks from steers receiving the RAC200 and 
RAC300 treatments for each tenderness attribute; there were also no differences in panelists 
ratings for steaks from steers receiving the CON and RAC200 treatments for all tenderness 
attributes.  
Treatment of steers with βAA caused no differences in juiciness (P = 0.2455), beef flavor 
(P = 0.1265), beef fat flavor (P = 0.3314), or off flavors (P = 0.8876) of steaks. 
 Gruber et al. (2008) reported that trained sensory panelists rated steaks from cattle fed 
dietary RH at 200 mg/hd/d lower for tenderness and juiciness compared to controls.  Hilton et al. 
(2009) reported that trained panelists rated steaks from ZH treated cattle lower for tenderness, 
juiciness, and beef flavor.  Garmyn et al. (2010) also reported that overall tenderness and 
sustained juiciness scores were reduced due to ZH supplementation, but found no differences in 
panelist rating for flavor attributes.  Disparities in WBSF and SSF values between treatments 
should indicate differences in trained sensory panelist evaluation.  In the current study, the shear 
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force and trained sensory panel results indicated the same trend in tenderness due to βAA 
supplementation of live cattle.  It is recognized that βAA supplementation increases fiber 
diameter in skeletal muscle (Gonzalez et al., 2007; Kellermeier et al., 2009).  Kellermeier et al. 
(2009) reported that, along with an increase in fiber diameter due to dietary ZH supplementation, 
strip loins from ZH treated cattle had a greater percent purge loss compared to controls.  The 
additional purge loss reported in ZH studies (Kellermeier et al., 2009) could be a contributing 
factor to differences in juiciness and flavor.  In the current study, cook loss was measured 
immediately after cooking; however, drip loss or purge before cooking or after the tempering 
period was not evaluated.  Further evaluation of these factors could provide insight into the 
factors driving juiciness and flavor differences in other research. 
Conclusions 
 Results of this study indicated that improvements in live animal performance and carcass 
traits occurred due to increased dose and potency of dietary βAA supplementation.  Average 
daily gain and F:G ratio was improved in a manner consistent with contemporary Ractopamine 
and Zilpaterol literature (Gruber et al., 2008; Kellermeier et al., 2009; Montgomery et al., 2009).  
However, differences in final BW between treatments was not as pronounced as that reported in 
other βAA studies (Elam et al., 2009; Gruber et al., 2009; Kellermeier et al., 2009; Scramlin et 
al., 2010). 
 Steers receiving dietary ZH supplementation generated the heaviest HCW, highest DP, 
and largest LMA.  Means separation indicated no differences between RAC treatments for 
HCW, DP, and LMA.  USDA yield grade and marbling score were reduced due to βAA 
supplementation of live cattle.  Reductions in marbling score due to treatment reduced the 
frequency of carcasses qualifying for an Upper 2/3 Choice premium.  The percentage of YG1 
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carcasses was increased and the percentage of YG3 carcasses was decreased due to treatment, 
with carcasses from steers receiving the ZIL treatment having the highest frequency of YG1 and 
lowest frequency of YG3 carcasses.    
Total saleable yield was improved with supplementation of βAA, and was highest for 
carcasses from steers receiving the RAC400 and ZIL treatments.  Treatment with βAA’s had the 
most pronounced effects on yield in subprimals from the round including: inside round, eye of 
round, shank meat, peeled knuckle, outside round, tri-tip, and quadriceps.  Additionally, 
treatment improved yield for the strip loin, 91’s trim, blade meat, and bone. 
 Steaks from steers supplemented with ZH had the toughest WBSF and SSF values, while 
also having the highest frequency of steaks shearing greater than 4.4 kg of WBSF.  Beta-agonist 
treatment also increased the frequency of steaks shearing greater than 20.0 kg SSF in the 
RAC400 and ZIL treatments.  For WBSF, SSF, and the frequency of steaks shearing greater than 
4.4 and 20.0 kg, steaks from steers receiving the CON and RAC200 treatments did not differ.  
Similar trends were detected by trained sensory panelists, who rated steaks from cattle receiving 
the ZIL and RAC400 treatments tougher for myofibrillar, connective tissue, and overall 
tenderness than steaks from all other treatments. 
 This study supports literature indicating that the growth and carcass traits are improved 
via dietary βAA supplementation, but also reinforces the negative impact βAA’s pose on meat 
quality and palatability.  Additionally, results from this study demonstrated minimal differences 
in growth and carcasses characteristics between RH supplementation at higher concentrations 
(300 and 400 mg/hd/d) compared to ZH that was provided in steer diets at recommended label 
dosages (6.8 g/ton).  Moreover, while ZIL treatment had a more pronounced effect on WBSF 
values, trained sensory panelists rated ZIL and RAC400 steaks similarly.  Lower potencies of 
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RH are optimal to mitigate issues with quality, tenderness, and palatability, albeit with lesser 
effects on performance and carcass characteristics. 
 Cattle feeders have the opportunity to improve efficiency and carcass yield via the use of 
βAA’s.  Yet, this research underlines the importance of judicious use of growth enhancement 
technologies to optimize cattle growth and beef quality.  Beta-agonist use should be matched 
with the biological type of cattle which will reduce issues with marbling and tenderness.  Doing 
so will enhance growth and yield in lower performing cattle, and preserve quality and 
palatability in leaner, faster gaining breeds.  
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Table 3.1. Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride 






CON RAC200 RAC300 RAC400 ZIL SEM P < FTRT 
In Weight
3 
544.15 541.58 540.60 542.67 542.45 2.72 0.9164 
Final Weight
4 

























Values in the same column that do not share a common superscript differ (P < 0.05).
 
1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, 
Greenfield, IN) fed at 200 or 300 mg/hd/d, or 400 mg/hd/d top dress ; ZIL = Zilpaterol 
hydrochloride (Merck Animal Health, Summit, NJ) fed at 6.8 g/ton.
 
2
Pen used as experimental unit.
 
3
In Weight = pen weight collected before initiation of treatment calculated with 4% shrink.
 
4






Table 3.2.  Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride 






CON RAC200 RAC300 RAC400 ZIL SEM P < FTRT 





















0.14 < 0.0001 
Mesenteric Fat, % 1.67 1.64 1.59 1.63 1.51 0.10 0.8429 










0.70 < 0.0001 
12-rib fat, cm 1.13 1.09 1.11 1.10 1.06 0.04 0.8631 

























Values that do not share a common superscript in the same row differ (P < 0.05). 
1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, 
Greenfield, IN) fed at 200 or 300 mg/hd/d, or 400 mg/hd/d top dress ; ZIL = Zilpaterol 
hydrochloride (Merck Animal Health, Summit, NJ) fed at 6.8 g/ton.
 
2
Pen used as experimental unit
 
3
Marbling score: 300 = Slight
00






Table 3.3.  Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride 






CON RAC200 RAC300 RAC400 ZIL SEM P < FTRT 













1.18 < 0.0001 
Choice 57.55 51.82 48.66 52.61 46.85 2.80 0.0973 
Select 40.22 45.62 48.92 45.17 50.43 2.74 0.1076 
No Roll 1.31 2.03 1.79 1.30 1.83 0.44 0.6890 
        
Hard Bone 0.52 0.39 0.13 0.66 0.76 0.26 0.4555 
Heavy HCW        
    > 950 lbs. 0.52 0.25 0.86 1.17 1.30 0.45 0.4448 
    > 1050 lbs. 0.00 0.00 0.12 0.12 0.13 0.09 0.7283 
        











Yield Grade 2 43.24 44.06 42.71 44.93 52.90 3.45 0.2332 











Yield Grade 4 6.59 5.67 4.73 4.21 3.27 1.37 0.4863 
Yield Grade 5 0.14 0.14 0.00 0.00 0.00 0.09 0.5799 
a,b,c
Values that do not share a common superscript in the same row differ (P < 0.05).
 
1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, 
Greenfield, IN) fed at 200 or 300 mg/hd/d, or 400 mg/hd/d top dress ; ZIL = Zilpaterol 
hydrochloride (Merck Animal Health, Summit, NJ) fed at 6.8 g/ton.
 
2
Pen used as experimental unit.
 
3







Figure 3.1.  Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride of steers on subsequent USDA Quality Grade 
distributions (values expressed as treatment mean frequency).  a,bLeast squares means (bars) not sharing a common superscript differ 
(P < 0.05).  
1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, Greenfield, IN) fed at 200 or 
300 mg/hd/d, or 400 mg/hd/d top dress ; ZIL = Zilpaterol hydrochloride (Merck Animal Health, Summit, NJ) fed at 6.8 g/ton.   


















































Figure 3.2.  Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride supplementation of steers on subsequent USDA Yield 
Grade distributions (values expressed as treatment mean frequency).  a,bLeast squares means (bars) not sharing a common superscript 
differ (P < 0.05).
  1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, Greenfield, IN) fed at 200 














4.73 4.21 3.27 
































Table 3.4. Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride supplementation of steers on 






CON RAC200 RAC300 RAC400 ZIL SEM P < FTRT 
Chuck roll 5.89 5.84 5.84 5.86 5.83 0.07 0.9583 
Chuck mock tender 0.86 0.88 0.88 0.89 0.90 0.01 0.1001 
Chuck flat 0.47 0.47 0.47 0.45 0.45 0.01 0.3598 
1 piece shoulder clod 4.55 4.62 4.60 4.64 4.69 0.04 0.1093 
Teres major 0.21 0.21 0.22 0.22 0.22 0.00 0.1810 
Pectoral muscle 0.62 0.65 0.66 0.63 0.64 0.02 0.4023 
Bnls Chuck Short Ribs 0.45 0.46 0.45 0.45 0.45 0.01 0.8858 
Ribeye roll 3.63 3.59 3.57 3.62 3.59 0.03 0.5701 
Brisket, boneless 2.84 2.82 2.82 2.91 2.95 0.05 0.1752 




































































Top butt 3.17 3.16 3.19 3.18 3.20 0.03 0.8017 
Short rib 1.35 1.34 1.36 1.33 1.33 0.01 0.2543 
Flank 0.51 0.52 0.52 0.52 0.53 0.01 0.5559 
Inside skirt 0.50 0.50 0.50 0.51 0.51 0.01 0.9578 
Outside skirt 0.39 0.40 0.39 0.39 0.38 0.01 0.3430 



































50’s trim 3.65 3.54 3.55 3.56 3.52 0.05 0.3838 








CON RAC200 RAC300 RAC400 ZIL SEM P < FTRT 
        
81’s trim 5.56 5.74 5.61 5.64 5.67 0.06 0.2938 




































Values that do not share a common superscript in the same row differ (P < 0.05).
 
1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, Greenfield, IN) fed at 200 or 













Table 3.5.  Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride 


















0.05 < 0.0001 





















0.37 < 0.0001 











Cook Loss, % 18.50 18.88 19.06 19.16 19.70 0.47 0.4923 
a-d
Values in the same column that do not share a common superscript differ (P < 0.05)
 
1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, 
Greenfield, IN) fed at 200 or 300 mg/hd/d, or 400 mg/hd/d top dress ; ZIL = Zilpaterol 
hydrochloride (Merck Animal Health, Summit, NJ) fed at 6.8 g/ton.
 
2





Table 3.6.  Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride 
supplementation of steers on subsequent trained sensory panel attributes of Longissimus 







































0.11 < 0.0001 
Juiciness 8.27 8.21 8.17 8.13 8.13 0.07 0.2455 
Beef Flavor 9.15 9.10 9.09 8.89 9.02 0.07 0.1265 
Beef Fat Flavor 7.51 7.44 7.34 7.33 7.37 0.07 0.3314 
Off Flavors 0.23 0.18 0.19 0.19 0.20 0.03 0.8876 
a-d
Values that do not share a common superscript in the same row differ (P < 0.05).
 
1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, 
Greenfield, IN) fed at 200 or 300 mg/hd/d, or 400 mg/hd/d top dress ; ZIL = Zilpaterol 
hydrochloride (Merck Animal Health, Summit, NJ) fed at 6.8 g/ton.
 
2
Pen used as experimental unit. 
3
Sensory panel scales: tenderness (1 = extremely tough, 15 = extremely tender); juiciness (1 = 
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1A 1/31/12 3/19/12  4/18/12 
2A 1/31/12 3/19/12  4/18/12 
3A 1/31/12 3/19/12  4/18/12 
4A 1/31/12 3/26/12 4/15/12 4/18/12 
5A 1/31/12 3/19/12  4/18/12 
6A 2/8/12 3/19/12  4/18/12 
7A 2/8/12 3/19/12  4/18/12 
8A 2/8/12 3/19/12  4/18/12 
9A 2/8/12 3/26/12 4/15/12 4/18/12 
10A 2/8/12 3/19/12  4/18/12 
1B 2/9/12 3/26/12  4/25/12 
2B 2/9/12 3/26/12  4/25/12 
3B 2/9/12 4/2/12 4/22/12 4/25/12 
4B 2/9/12 3/26/12  4/25/12 
5B 2/9/12 3/26/12  4/25/12 
6B 2/9/12 3/26/12  4/25/12 
7B 2/9/12 3/26/12  4/25/12 
8B 2/9/12 3/26/12  4/25/12 
9B 2/9/12 3/26/12  4/25/12 
10B 2/9/12 4/2/12 4/22/12 4/25/12 
1C 3/5/12 4/2/12  5/2/12 
2C 3/5/12 4/2/12  5/2/12 
3C 3/5/12 4/2/12  5/2/12 
4C 3/5/12 4/9/12 4/29/12 5/2/12 
5C 3/5/12 4/2/12  5/2/12 
6C 2/21/12 4/2/12  5/2/12 
7C 2/21/12 4/2/12  5/2/12 
8C 2/21/12 4/9/12 4/29/12 5/2/12 
9C 2/21/12 4/2/12  5/2/12 
10C 2/21/12 4/2/12  5/2/12 
1D 3/20/12 4/9/12  5/9/12 
2D 3/20/12 4/9/12  5/9/12 
3D 3/20/12 4/9/12  5/9/12 
4D 3/20/12 4/9/12  5/9/12 
5D 3/20/12 4/16/12 5/6/12 5/9/12 
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6D 3/13/12 4/9/12  5/9/12 
7D 3/13/12 4/16/12 5/6/12 5/9/12 
8D 3/13/12 4/9/12  5/9/12 
9D 3/13/12 4/9/12  5/9/12 











































Final Head Count 
01A 1 CON 99 0 1 98 
02A 1 RAC200 99 0 1 98 
03A 1 RAC300 103 0 0 103 
04A 1 ZIL 100 0 0 100 
05A 1 RAC400 102 1 0 101 
06A 1 RAC400 104 1 2 101 
07A 1 CON 104 0 1 103 
08A 1 RAC200 103 1 0 102 
09A 1 ZIL 106 0 2 104 
10A 1 RAC300 103 1 0 101 
01B 2 RAC400 101 0 0 101 
02B 2 RAC200 100 1 0 99 
03B 2 ZIL 99 1 1 97 
04B 2 RAC300 101 0 1 100 
05B 2 CON 100 0 2 98 
06B 2 RAC200 96 0 0 100 
07B 2 RAC400 93 0 1 92 
08B 2 CON 92 0 0 92 
09B 2 RAC300 95 0 1 94 
10B 2 ZIL 93 0 0 93 
01C 3 RAC400 93 0 2 92 
02C 3 CON 92 0 0 92 
03C 3 RAC300 93 0 0 93 
04C 3 ZIL 93 0 0 93 
05C 3 RAC200 91 1 0 90 
06C 3 CON 100 0 0 100 
07C 3 RAC400 103 1 0 102 
08C 3 ZIL 102 1 3 98 
09C 3 RAC300 103 0 0 103 
10C 3 RAC200 104 0 2 102 
01D 4 RAC400 96 0 0 96 
02D 4 RAC200 98 0 1 97 
03D 4 RAC300 94 0 1 93 
04D 4 CON 97 0 0 97 
05D 4 ZIL 96 0 0 96 
06D 4 RAC200 91 1 0 90 
07D 4 ZIL 91 0 0 91 
08D 4 RAC400 91 0 0 91 
09D 4 CON 92 1 0 91 
10D 4 RAC300 94 0 0 94 
Study Totals 3907 11 22 3878 
a
Treatments: CON = Control; RAC = Ractopamine hydrochloride fed at 200 or 300 
mg/hd/d, or 400 mg/hd/d top dress ; ZIL = Zilpaterol hydrochloride fed at 6.8 g/ton. 
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01A CON 982000000974001 4/9/12 Removal Abscess 
02A RAC200 900086000756350 3/27/12 Removal Buller 
05A RAC400 900086000770449 3/22/12 Dead Digestive 
06A RAC400 982000174096124 3/20/12 Removal SEP 
06A RAC400 982000054504743 3/23/12 Removal Bloat 
06A RAC400 982000174096154 4/8/12 Dead Abscess 
07A CON 3005889881 3/19/12 Removal Bloat 
08A RAC200 982000170039801 4/4/12 Dead Abscess 
09A ZIL 985152002875883 3/25/12 Removal SEP/Eye Injury 
09A ZIL 900086000770479 3/25/12 Removal Bloat 
10A RAC300 No EID 3/25/12 Dead Digestive 
10A RAC200 3000848544 4/25/12 Removal Cripple 
02B RAC200 982000200112099 4/10/12 Dead Digestive 
03B ZIL 982000200112104 4/2/12 Removal Abscess 
03B ZIL 985152002875964 4/9/12 Dead Other 
04B RAC300 982000156402356 4/4/12 Removal Fat Pneumonia 
05B CON 982000173357947 4/2/12 Removal Cripple 
05B CON 982000133940373 4/8/12 Removal Cripple 
07B RAC400 982000133937113 3/28/12 Removal SEP 
09B RAC300 982000156404005 3/29/12 Removal Buller 
01C RAC400 900086000760437 4/2/12 Removal Hard Breather 
01C RAC400 900086000832962 4/30/12 Removal Abscess 
05C RAC200 985152002877642 4/6/12 Dead Digestive 
07C RAC400 982000054148714 4/7/12 Dead Digestive 
08C ZIL 900086000765579 4/2/12 Removal SEP 
08C ZIL 900086000760197 4/7/12 Removal Fat Pneumonia 
08C ZIL 900086000755913 4/10/12 Dead Digestive 
08C ZIL 982000061872358 4/23/12 Removal Buller 
10C RAC200 900086000763156 4/2/12 Removal SEP 
02D RAC200 900086001053132 4/27/12 Removal Fat Pneumonia 
03D RAC300 900086000758498 5/2/12 Removal Fat Pneumonia  
06D RAC200 982000127908335 4/17/12 Dead Digestive 





















Table A.4. Carcass fabrication selection matrix 
 Hot Carcass Weight 
Average Backfat Replicate Mean ± 30 lbs 
Lean (< 0.32”) n = 2 
Low Average (0.33 - 0.44”) n = 2 
High Average (0.45 - 0.60”) n = 2 
Fat (> 0.60”) n = 2 
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Table A.5.  Fabrication Item List 
Chuck/Brisket Rib/Plate Loin/Flank Round 
Chuck Initial Wt. Rib Initial Wt. Tenderloin Initial Wt. Inside Round Initial Wt. 
SM Chk eye, 1x1 Rib Lipon, 2x2 Tenderloin Inside Round 1/4" Inside round 
Scottie/Mock tender Rib Butterfly blade meat Tenderloin 50's Inside Round Aitch bone 
Chuck flat Rib Backribs Tenderloin Tissue Inside Round 65's 
Subscap Rib Cartilage Strip Loin Initial Wt. 
(including chine) 
Inside Round Tissue 
Paddle bone Rib Chine/Feather bones Strip Loin Bnls Strip loin, 
1x0 
Knuckle Initial Wt. 
Neck bones Rib Backstrap Strip Loin Bones (Chine, flat, 
feather, button, & rib) 
Knuckle Peeled 
Chuck Backstrap Rib 50's Strip Loin Tissue Knuckle bone 
Chuck Cartilage Rib Tissue Top Butt Initial Wt. Knuckle 65's 
Chuck Neck Cap Navels Initial Wt. 1 pc Top Butt Knuckle Tissue 
Chuck Neck trim Navels 11" Navel Butt bone/Pin Bone  
Chuck 93% Chuck Navel 65 Top Butt Sirloin-86's Eye of Round Initial Wt. 
Chuck 81% Chuck Navel bones Top Butt Tissue Eye of Round 
Chuck 65's Navels Finger meat Loin Tail Initial Wt. Eye of Round Round 86's 
Chuck Fish Fat Navel 50’s Loin tail - 81 Eye of Round Tissue 
Chuck Tissue Navel Tissue Loin Tail Tissue Round Flat Initial Wt. 
Clod Initial Wt. Short Rib Initial Wt. Loin Tail Bones Round Flat 
1 pc Clod Short Rib 11" Short ribs Flank Initial Wt. Round Flat Heel 
Clod Teres major Short Rib Bones Flank Round Flat Rat muscle 
Clod Blade meat Short Rib Rectangular Blade meat Flank 50's Round Flat Cartilage 
Clod Chuck - 81's Short Rib L-shape Flank Tissue Round Flat Round 86's 
Clod 65's Short Rib Finger meat (81's) Flank Skin Round Flat 65's 
Clod Tissue Short Rib Baby Bones 81 Rose meat Round Flat Tissue 
Pectoral/Foreshank Initial Wt. Short Rib 50's Hanging Tender Initial Wt. Hindshank Initial Wt. 
Pectoral Short Rib Tissue Hanging Tender 
Diaphram/fat 
Hindshank Peeled Shank 
Foreshank  Hanging tender Hindshank Bones 
Pectoral/Foreshank Bones  Skirts Initial Wt. Hindshank Skin 
Pectoral/Foreshank Tendons  Inside Skirt  
Pectoral/Foreshank Chuck - 81's  Outside Skirt  
Pectoral/Foreshank Tissue  Skirt Skin  
CSR Initial Wt.  Diaphragm  






CSR Bones  Flap Initial Wt.  
CSR Chuck - 81's  Flap  
CSR Tissue  Flap Tissue  
Brisket Initial Wt.  Bottom Butt Initial Wt.  
Brisket Bnls Brisket  Tri-tip  
Brisket bone  Ball-tip  
Brisket Finger meat  Bottom Butt Tissue  
Brisket 50's    
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Figure A.2.  Effect of Ractopamine hydrochloride and Zilpaterol hydrochloride of steers on subsequent marbling score distribution 
(values expressed at treatment mean frequency).  
a,b
Least square means (bars) lacking a common superscript differ (P < 0.05).
  
1
Treatments: CON = Control; RAC = Ractopamine hydrochloride (Elanco Animal Health, Greenfield, IN) fed at 200 or 300 mg/hd/d, 
or 400 mg/hd/d top dress ; ZIL = Zilpaterol hydrochloride (Merck Animal Health, Summit, NJ) fed at 6.8 g/ton. 
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